OT ULTRALINK METER
Report
- Report Number
- 3008382007-2013-18562
- Event Type
- Injury
- Date Received
- June 27, 2013
- Report Date
- June 12, 2013
- Manufacturer
- LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
- Product Code
- NBW
- PMA / PMN Number
- K073231
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- PATIENT
Narratives
LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.
ON (B)(6) 2013, THE LAY USER/PATIENT CONTACTED LIFESCAN (LFS) ALLEGING HER ONETOUCH ULTRALINK METER WAS NOT POWERING ON WHEN SHE TRIED TO TEST HER BLOOD GLUCOSE AFTER THE METER GOT WET AT AN AMUSEMENT PARK. THE COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER CARE ADVOCATE (CCA) DOCUMENTATION. THE PATIENT REPORTED, THE ALLEGED ISSUE FIRST OCCURRED ON (B)(6) 2013 IN THE EVENING. THE PATIENT REPORTED USING INSULIN PUMP THERAPY WITH HUMALOG TO MANAGE HER DIABETES. IT IS UNCLEAR IF THE PATIENT MADE ANY CHANGES TO HER NORMAL DIABETES ROUTINE DUE TO THE ALLEGED ISSUE. THE PATIENT REPORTED 2 HOURS AFTER THE ALLEGED ISSUE OCCURRED, SHE DEVELOPED SYMPTOMS OF ¿FREQUENT URINATION, THIRSTY AND HEADACHE.¿ THE PATIENT REPORTED ON (B)(6) 2013 AT 10PM SHE HAD 3.3 UNITS OF HUMALOG INSULIN. THE PATIENT DENIED TESTING HER BLOOD GLUCOSE ON ANOTHER DEVICE. DURING THE TIME OF TROUBLESHOOTING, THE CCA CONFIRMED THERE WAS MISUSE OF THE SUBJECT METER. REPLACEMENT PRODUCTS WERE SENT TO THE PATIENT. THIS COMPLAINT IS BEING REPORTED BECAUSE, THE PATIENT CLAIMS DUE TO THE ALLEGED ISSUE THE PATIENT DEVELOPED SYMPTOMS SUGGESTIVE OF HYPERGLYCEMIA AND REQUIRED SELF TREATMENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 294246 | OT ULTRALINK METER | GLUCOSE MONITORING SYS/KIT | NBW | LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL | 3435821 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Life Threatening| R |